Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1982 1
1986 1
1988 1
1993 1
1995 1
1998 1
2007 2
2008 2
2009 1
2010 2
2011 1
2013 1
2014 2
2015 2
2019 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Non-secretory multiple myeloma: Diagnosis and management.
Charliński G, Jurczyszyn A. Charliński G, et al. Adv Clin Exp Med. 2022 Jan;31(1):95-100. doi: 10.17219/acem/141455. Adv Clin Exp Med. 2022. PMID: 34637200 Free article. Review.
Multiple myeloma (MM) is one of the most commonly diagnosed blood cancers. ...Currently, both the diagnosis and treatment of non-secretory MM are the same as those of secretory MM. Due to the rarity of non-secretory MM, most findings are
Multiple myeloma (MM) is one of the most commonly diagnosed blood cancers. ...Currently, both the diagnosis and treatment of
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, Palumbo A, Jagannath S, Blade J, Lonial S, Dimopoulos M, Comenzo R, Einsele H, Barlogie B, Anderson K, Gertz M, Harousseau JL, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Richardson P, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Rajkumar SV, Durie BG; International Myeloma Working Group. Dispenzieri A, et al. Leukemia. 2009 Feb;23(2):215-24. doi: 10.1038/leu.2008.307. Epub 2008 Nov 20. Leukemia. 2009. PMID: 19020545 Review.
There are three major indications for the FLC assay in the evaluation and management of multiple myeloma and related plasma cell disorders (PCD). In the context of screening, the serum FLC assay in combination with serum protein electrophoresis (PEL) a …
There are three major indications for the FLC assay in the evaluation and management of multiple myeloma and related plasma
Non-secretory myeloma: a clinician's guide.
Lonial S, Kaufman JL. Lonial S, et al. Oncology (Williston Park). 2013 Sep;27(9):924-8, 930. Oncology (Williston Park). 2013. PMID: 24282993 Review.
The treatment of patients with multiple myeloma has dramatically changed over the past 10 years due to an improved understanding of plasma cell biology and the development of new targets. ...Newer methods of assessment for plasma cell dis …
The treatment of patients with multiple myeloma has dramatically changed over the past 10 years due to an improved understandi …
Non-secretory myeloma in young man mimicking the Gorham disease: case report and the literature review.
Ferjani HL, Mariem M, Affess H, Maatallah K, Kaffel D, Jenzri M, Hamdi W. Ferjani HL, et al. Rom J Intern Med. 2022 Mar 17;60(1):77-84. doi: 10.2478/rjim-2021-0036. Print 2022 Mar 1. Rom J Intern Med. 2022. PMID: 34610233 Free article. Review.
Multiple myeloma is a neoplasm of plasma cells affecting mostly the elderly with incidence peaks between 60 and 70 years. This disease is exceedingly rare in younger people, especially in adults under 30-year-old. Non-secretory multiple
Multiple myeloma is a neoplasm of plasma cells affecting mostly the elderly with incidence peaks between 60 and 70 year
Myelomagenesis: capturing early microenvironment changes.
Korde N, Maric I. Korde N, et al. Semin Hematol. 2011 Jan;48(1):13-21. doi: 10.1053/j.seminhematol.2010.11.004. Semin Hematol. 2011. PMID: 21232654 Free PMC article. Review.
The classification includes, in addition to precursor lesion MGUS, plasma cell myeloma, plasmacytoma, immunoglobulin deposition diseases, and osteosclerotic myeloma. Plasma cell myeloma is further divided into symptomatic plasma
The classification includes, in addition to precursor lesion MGUS, plasma cell myeloma, plasmacytoma, immunoglobulin de …
Plasma cell myeloma in unusually young patients: a report of two cases and review of the literature.
Ishida T, Dorfman HD. Ishida T, et al. Skeletal Radiol. 1995 Jan;24(1):47-51. doi: 10.1007/BF02425947. Skeletal Radiol. 1995. PMID: 7709252 Review.
Two cases of plasma cell myeloma in unusually young patients are reported. One was a case of multiple myeloma involving the skull and ribs in a 23-year-old woman, the other of solitary myeloma of the tibia in a 21-year-old man. ...Plas
Two cases of plasma cell myeloma in unusually young patients are reported. One was a case of multiple myeloma
Serum-free light-chain assay: clinical utility and limitations.
Bhole MV, Sadler R, Ramasamy K. Bhole MV, et al. Ann Clin Biochem. 2014 Sep;51(Pt 5):528-42. doi: 10.1177/0004563213518758. Epub 2014 Jan 31. Ann Clin Biochem. 2014. PMID: 24489083 Review.
The contribution and significance of the sFLC assay in the management of light-chain myeloma, primary amyloid light-chain (AL) amyloidosis and non-secretory myeloma are well recognised and will be addressed in this review. The aim of this article is to …
The contribution and significance of the sFLC assay in the management of light-chain myeloma, primary amyloid light-chain (AL) amyloi …
The evolving use of serum free light chain assays in haematology.
Pratt G. Pratt G. Br J Haematol. 2008 May;141(4):413-22. doi: 10.1111/j.1365-2141.2008.07079.x. Epub 2008 Mar 3. Br J Haematol. 2008. PMID: 18318757 Free article. Review.
The new FLC assay has enabled the detection of monoclonal protein in some patients with non-secretory myeloma and amyloidosis that were previously undetectable. FLC measurements are quantitative, correlating with disease activity, and are an advance in monito …
The new FLC assay has enabled the detection of monoclonal protein in some patients with non-secretory myeloma and amylo …
18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
Dammacco F, Rubini G, Ferrari C, Vacca A, Racanelli V. Dammacco F, et al. Clin Exp Med. 2015 Feb;15(1):1-18. doi: 10.1007/s10238-014-0308-3. Epub 2014 Sep 14. Clin Exp Med. 2015. PMID: 25218739 Review.
Conventional radiographic skeletal survey has been for many years the gold standard to detect the occurrence of osteolytic lesions in patients with multiple myeloma (MM). However, the introduction of more sensitive imaging procedures has resulted in an updated anato …
Conventional radiographic skeletal survey has been for many years the gold standard to detect the occurrence of osteolytic lesions in patien …
Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
Mayo MM, Johns GS. Mayo MM, et al. Contrib Nephrol. 2007;153:44-65. doi: 10.1159/000096760. Contrib Nephrol. 2007. PMID: 17075223 Review.
These patients include non-secretory multiple myeloma, amyloidosis and light chain deposition disease. In addition other uses for the test include monitoring response to treatment and earlier detection of relapse in all patients with plasma c
These patients include non-secretory multiple myeloma, amyloidosis and light chain deposition disease. In additi …
21 results